Lisa Lewis is a Director at FasterCures and has built her career over 27 years in biomedical research, from academia to the pharmaceutical industry. She has held roles in clinical development and medical affairs at Johnson & Johnson, Novartis Oncology, Celgene, Bristol-Myers Squibb, Flatiron Health, The Medicines Company, AstraZeneca, G1 Therapeutics, Allergan, and Immunocore. Lewis began her career in preclinical research at the Pediatric Hematopoiesis Research Laboratory at the Mount Sinai Hospital/Icahn School of Medicine and Northwell Health.

Early in her career, she managed pediatric and adult hematology/oncology clinical trials at Mount Sinai Hospital and Queens Medical Associates Center for Cancer and Blood Disorders at Northwell Health. She also served as a research associate at The New York Academy of Medicine for the Center for Adherence Support Evaluation. She holds a Bachelor of Science in biology/pre-medicine from Stony Brook University, a Master of Public Health from New York Medical College and she is currently pursuing a Master of Science in Bioethics at Harvard Medical School.